Vanda Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Vanda Pharmaceuticals has a total shareholder equity of $544.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $648.4M and $103.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$388.26m |
Equity | US$544.91m |
Total liabilities | US$103.53m |
Total assets | US$648.44m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0LKB's short term assets ($432.9M) exceed its short term liabilities ($87.7M).
Long Term Liabilities: 0LKB's short term assets ($432.9M) exceed its long term liabilities ($15.8M).
Debt to Equity History and Analysis
Debt Level: 0LKB is debt free.
Reducing Debt: 0LKB has not had any debt for past 5 years.
Debt Coverage: 0LKB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 0LKB has no debt, therefore coverage of interest payments is not a concern.